microRNA

Researchers at Pusan National University in South Korea have developed an artificial intelligence tool that maps where microRNAs bind to circular RNAs. The tool is aimed at helping scientists better understand gene regulation and the role circular RNAs play in diseases such as cancer, where microRNA interactions are increasingly seen as important drug targets.

A newly published review examines the use of miRNA-loaded nanocarriers as a therapeutic approach for osteosarcoma, an aggressive bone cancer that primarily affects children and young adults. The article assesses current research on how these nanoparticles can deliver microRNA to tumours, discussing their potential to improve targeted treatment while noting challenges in delivery efficiency, safety, and translation from laboratory studies to clinical practice.